# Salarius Pharmaceuticals, LLC: Form D filings

Salarius Pharmaceuticals, LLC, a pharmaceuticals company in Holladay, UT, filed 3 Form D notices with the SEC in 2016. The latest, on November 21, 2016, reports $131,500 sold of a $131,500 offering to 7 investors.

Find out what Salarius Pharmaceuticals, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Salarius%20Pharmaceuticals%2C%20LLC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Salarius%20Pharmaceuticals%2C%20LLC&page=%2Fdata%2Fform-d%2Fcompany%2Fsalarius-pharmaceuticals-llc-1661178)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Salarius%20Pharmaceuticals%2C%20LLC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Salarius%20Pharmaceuticals%2C%20LLC&page=%2Fdata%2Fform-d%2Fcompany%2Fsalarius-pharmaceuticals-llc-1661178)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Utah](https://specstream.ai/data/form-d/state/utah): 660 rows, by operating companies, filed since November 1, 2024, $33, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/utah
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 5361 South 2110 East, Holladay, UT, 84117
- Phone: (203) 546-0376
- Industry: Pharmaceuticals
- Entity type: Limited Liability Company
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1661178

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Nov 21, 2016 | New notice | $131,500 | $131,500 | $0 | 7 | Mar 22, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1661178/000166117816000003/0001661178-16-000003-index.htm) |
| Nov 21, 2016 | New notice | $108,335 | $108,335 | $0 | 8 | Mar 21, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1661178/000166117816000002/0001661178-16-000002-index.htm) |
| Apr 4, 2016 | New notice | $2,745,000 | $775,000 | $1,970,000 | 3 | Apr 30, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1661178/000166117816000001/0001661178-16-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Sunil J. Sharma | Executive Officer, Director, Promoter |  |
| Jonathan J. Northrup | Executive Officer, Director, Promoter |  |
| David J. Bearss | Executive Officer, Director, Promoter |  |
| David J. Arthur | Executive Officer |  |

[Every Form D from the week of Nov 21, 2016](https://specstream.ai/data/form-d/week/2016-11-21) · [All recent filings in Utah](https://specstream.ai/data/form-d/state/utah) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Salarius Pharmaceuticals, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).